SAMANTHA GRAY: Open Payments
NPI 1124370010 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,110 in 107 payments from 24 companies in 2025. Trend: 2023 $1,617 · 2024 $2,235 · 2025 $2,110
Food & beverage: $2,110
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $342 |
| PFIZER INC. | 13 | $207 |
| ABBVIE INC. | 9 | $184 |
| GlaxoSmithKline, LLC. | 12 | $183 |
| Abbott Laboratories | 9 | $155 |
| Novo Nordisk Inc | 8 | $136 |
| Lilly USA, LLC | 6 | $112 |
| Corcept Therapeutics | 3 | $97 |
| Astellas Pharma US Inc | 4 | $93 |
| SANOFI-AVENTIS U.S. LLC | 4 | $90 |
Products named: BREZTRI, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, NURTEC ODT, TZIELD, JARDIANCE, Korlym, QULIPTA.
Industry payments across DE — which companies pay providers there.
